Deutsche Märkte geschlossen

Baxter International Inc. (BAX)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
40,33-1,79 (-4,25%)
Börsenschluss: 04:00PM EDT
40,33 0,00 (0,00%)
Nachbörse: 07:48PM EDT

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Sektor(en)Healthcare
BrancheMedical Instruments & Supplies
Vollzeitmitarbeiter60.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Jose E. AlmeidaChairman of the Board, President & CEO3,62MN/A1962
Mr. Joel T. GradeExecutive VP & CFO829,82kN/A1971
Ms. Heather KnightExecutive VP & Group President of Medical Products and Therapies1,63MN/A1972
Mr. Alok Sonig B.E., MbaExecutive VP & Group President of Pharmaceuticals1,56MN/A1972
Mr. Christopher A. TothExecutive VP & Group President of Kidney Care5,26MN/A1980
Mr. Talvis P. LoveSenior VP & Chief Information OfficerN/AN/A1968
Ms. Tobi Karchmer M.D., M.S.Senior VP and Chief Medical & Scientific OfficerN/AN/AN/A
Ms. Clare TrachtmanVice President of Investor RelationsN/AN/AN/A
Mr. David S. RosenbloomExecutive VP & General Counsel776,51kN/A1960
Ms. Stacey Eisen?Senior Vice President, Chief Communications Officer & Corporate Marketing?N/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Corporate Governance

Baxter International Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 6. Die grundlegenden Scores sind Audit: 6, Vorstand: 6, Shareholderrechte: 1, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.